Corient Private Wealth’s Helmerich & Payne HP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$278K Buy
8,505
+1,698
+25% +$63.5K ﹤0.01% 2606
2026
Q1
$245K Sell
6,807
-1,875
-22% -$63.9K ﹤0.01% 2437
2025
Q4
$250K Sell
8,682
-899
-9% -$23.9K ﹤0.01% 2296
2025
Q3
$212K Buy
+9,581
New +$177K ﹤0.01% 2327
2025
Q1
Sell
-6,614
Closed -$212K 2354
2024
Q4
$212K Sell
6,614
-49
-0.7% -$1.66K ﹤0.01% 2086
2024
Q3
$203K Sell
6,663
-13,431
-67% -$464K ﹤0.01% 2220
2024
Q2
$726K Buy
20,094
+1,062
+6% +$40.8K ﹤0.01% 1463
2024
Q1
$800K Buy
19,032
+17
+0.1% +$643 ﹤0.01% 1397
2023
Q4
$689K Buy
19,015
+4,075
+27% +$158K ﹤0.01% 1451
2023
Q3
$630K Buy
14,940
+2,564
+21% +$107K ﹤0.01% 1369
2023
Q2
$439K Buy
+12,376
New +$422K ﹤0.01% 1515
2023
Q1
Sell
-3,941
Closed -$213K 2031
2022
Q4
$213K Buy
+3,941
New +$188K ﹤0.01% 1469

Other funds holding HP

Corient Private Wealth's HP Position: Q2 2026 in Review

Corient Private Wealth increased its Helmerich & Payne (HP) stake by 25% in Q2 2026, buying an estimated $63.5K and bringing the position to 8,505 shares worth $278K. The position accounts for ﹤0.01% of the portfolio, ranked #2606.

Corient Private Wealth first reported a position in HP in Q4 2022 and has held it in 12 quarters since. The position peaked at $800K in Q1 2024. 374 funds tracked by Wall St. Rank hold HP as of Q2 2026.

  • Corient Private Wealth held 8,505 shares of Helmerich & Payne worth $278K as of Q2 2026.
  • Corient Private Wealth bought 1,698 Helmerich & Payne shares in Q2 2026, an estimated $63.5K.
  • Helmerich & Payne made up ﹤0.01% of Corient Private Wealth's portfolio in Q2 2026, its #2606 holding.
  • Corient Private Wealth first reported a position in Helmerich & Payne in Q4 2022 and has held it in 12 quarters since.
  • Corient Private Wealth's Helmerich & Payne position peaked at $800K in Q1 2024.
  • 374 funds tracked by Wall St. Rank held Helmerich & Payne as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.